Circulating microRNAs in relation to EGFR status and survival of lung adenocarcinoma in female non-smokers

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Zhang, Huan ^a   Su, Yuliang ^a   Xu, Fangxiu ^a   Kong, Jinyu ^a   Yu, Herbert ^b   Qian, Biyun ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA; MICRORNA 122; MICRORNA 195; PROTEIN TYROSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ASIAN; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EGFR GENE; FEMALE; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; MIDDLE AGED; MUTANT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SENSITIVITY AND SPECIFICITY; SMOKING; VERY ELDERLY; WILD TYPE;

ADENOCARCINOMA; FEMALE; HUMANS; LUNG NEOPLASMS; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SMOKING; SURVIVAL ANALYSIS;

EID: 84896715270     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081408     Document Type: Article

References (41)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108. doi:10.3322/canjclin.55.2.74. PubMed: 15761078. (Pubitemid 40372904)
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96. doi:10.3322/CA.2007.0010. PubMed: 18287387. (Pubitemid 351521864)
3. Wakelee HA, Chang ET, Gomez SL, Keegan TH, Feskanich D et al. (2007) Lung cancer incidence in never smokers. J Clin Oncol 25: 472-478. doi:10.1200/JCO.2006.07.2983. PubMed: 17290054. (Pubitemid 350002951)
4. Boffetta P, Järvholm B, Brennan P, Nyrén O (2001) Incidence of lung cancer in a large cohort of non-smoking men from Sweden. Int J Cancer 94: 591-593. doi:10.1002/ijc.1507. PubMed: 11745449.
5. Toh CK, Wong EH, Lim WT, Leong SS, Fong KW et al. (2004) The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysis. Chest 126: 1750-1756. doi:10.1378/chest.126.6.1750. PubMed: 15596669.
6. Nordquist LT, Simon GR, Cantor A, Alberts WM, Bepler G (2004) Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest 126: 347-351. doi:10.1378/chest.126.2.347. PubMed: 15302716. (Pubitemid 39093415)
7. Chen X, Ba Y, Ma L, Cai X, Yin Y et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006. doi:10.1038/cr.2008.282. PubMed: 18766170.
8. Gao W, Shen H, Liu L, Xu J, Shu Y (2011) MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol 137: 557-566. doi:10.1007/s00432-010-0918-4. PubMed: 20508945.
9. Shen J, Todd NW, Zhang H, Yu L, Lingxiao X et al. (2011) Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest 91: 579-587. doi:10.1038/labinvest.2010.194. PubMed: 21116241.
10. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518. doi:10.1073/pnas.0804549105. PubMed: 18663219.
11. Heagerty PJ, Zheng Y (2005) Survival model predictive accuracy and ROC curves. Biometrics 61: 92-105. doi:10.1111/j.0006-341X.2005.030814.x. PubMed: 15737082. (Pubitemid 40380968)
12. The R Project for Statistical Computing. Available: http://www.rproject. org/. Accessed 2013 October 26
13. survivalROC. Available: http://cran.r-project.org/web/packages/ survivalROC/index.html Accessed 2013 Jan 13
14. Lee YJ, Cho BC, Jee SH, Moon JW, Kim SK et al. (2010) Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer. J Clin Oncol 28: 487-492. doi:10.1200/JCO.2009.24.5480. PubMed: 20008630.
15. Sun S, Schiller JH, Gazdar AF (2007) Lung cancer in never smokers - a different disease. Nat Rev Cancer 7: 778-790. doi:10.1038/nri2172. PubMed: 17882278. (Pubitemid 47463669)
16. Brundage MD, Davies D, Mackillop WJ (2002) Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 122: 1037-1057. doi:10.1378/chest.122.3.1037. PubMed: 12226051.
17. Herbst RS, Heymach JV, Lippman SM (2008). Lung Cancer - N Engl J Med 359: 1367-1380.
18. Stabile LP, Dacic S, Land SR, Lenzner DE, Dhir R et al. (2011) Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome. Clin Cancer Res 17: 154-164. doi:10.1158/1078-0432.CCR-10-0992. PubMed: 21062926.
19. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M et al. (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801. doi:10.1056/NEJMoa050995. PubMed: 16251535. (Pubitemid 41549891)
20. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070. doi:10.1158/0008-5472.CAN-05-1783. PubMed: 16103053. (Pubitemid 41161233)
21. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW et al. (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13: 48-57. doi:10.1016/j.ccr.2007.12.008. PubMed: 18167339.
22. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H et al. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756. doi:10.1158/0008-5472.CAN-04-0637. PubMed: 15172979. (Pubitemid 38697282)
23. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198. doi:10.1016/j.ccr.2006.01.025. PubMed: 16530703. (Pubitemid 43357945)
24. Hu Z, Chen X, Zhao Y, Tian T, Jin G et al. (2010) Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28: 1721-1726. doi:10.1200/JCO.2009.24.9342. PubMed: 20194856.
25. Liu XG, Zhu WY, Huang YY, Ma LN, Zhou SQ et al. (2012) High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer. Med Oncol 29: 618-626. doi: 10.1007/s12032-011-9923-y. PubMed: 21516486.
26. Silva J, García V, Zaballos A, Provencio M, Lombardía L et al. (2011) Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. Eur Respir J 37: 617-623. doi:10.1183/09031936.00029610. PubMed: 20595154.
27. Lin Q, Mao W, Shu Y, Lin F, Liu S et al. (2012) A cluster of specified microRNAs in peripheral blood as biomarkers for metastatic non-small-cell lung cancer by stem-loop RT-PCR. J Cancer Res Clin Oncol 138: 85-93. doi:10.1007/s00432-011-1068-z. PubMed: 22009180.
28. Yuxia M, Zhennan T, Wei Z (2012) Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis. J Cancer Res Clin Oncol 138: 2045-2050. doi:10.1007/s00432-012-1285-0. PubMed: 22806310.
29. Chen Q, Si Q, Xiao S, Xie Q, Lin J et al. (2013) Prognostic significance of serum miR-17-5p in lung cancer. Med Oncol 30: 353. doi:10.1007/s12032-012- 0353-2. PubMed: 23263848.
30. Wang Y, Gu J, Roth JA, Hildebrandt MA, Lippman SM et al. (2013) Pathway-Based Serum microRNA Profiling and Survival in Patients with Advanced Stage Non-Small Cell. Lung Cancer - Cancer Res 73: 4801-4809.
31. Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP et al. (2009) MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 50: 113-121. doi:10.1016/S0168-8278(09)60290-7. PubMed: 19441017.
32. Liu Q, Fu H, Sun F, Zhang H, Tie Y et al. (2008) miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 36: 5391-5404. doi:10.1093/nar/gkn522. PubMed: 18701644.
33. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J et al. (2010) Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251: 499-505. doi:10.1097/SLA. 0b013e3181cc939f. PubMed: 20134314.
34. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309: 1577-1581. doi:10.1126/science.1113329. PubMed: 16141076. (Pubitemid 41266486)
35. Esau C, Davis S, Murray SF, Yu XX, Pandey SK et al. (2006) miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3: 87-98. doi:10.1016/j.cmet.2006.01.005. PubMed: 16459310.
36. Gatfield D, Le Martelot G, Vejnar CE, Gerlach D, Schaad O et al. (2009) Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev 23: 1313-1326. doi:10.1101/gad.1781009. PubMed: 19487572.
37. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S et al. (2007) Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67: 6092-6099. doi:10.1158/0008-5472.CAN-06-4607. PubMed: 17616664. (Pubitemid 47037488)
38. Bai S, Nasser MW, Wang B, Hsu SH, Datta J et al. (2009) MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem 284: 32015-32027. doi:10.1074/jbc.M109. 016774. PubMed: 19726678.
39. Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW et al. (2009) MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 49: 1571-1582. doi:10.1002/hep.22806. PubMed: 19296470.
40. Zeng C, Wang R, Li D, Lin XJ, Wei QK et al. (2010) A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. Hepatology 52: 1702-1712. doi:10.1002/hep.23875. PubMed: 21038412.
41. Lan Q, Hsiung CA, Matsuo K, Hong YC, Seow A et al. (2012) Genomewide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet 44: 1330-1335. doi:10.1038/ng.2456. PubMed: 23143601.